X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs PFIZER - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA PFIZER SANOFI INDIA/
PFIZER
 
P/E (TTM) x 34.6 33.1 104.4% View Chart
P/BV x 6.9 4.9 140.8% View Chart
Dividend Yield % 1.3 0.8 169.4%  

Financials

 SANOFI INDIA   PFIZER
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
PFIZER
Mar-17
SANOFI INDIA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs4,5602,055 221.9%   
Low Rs4,4001,651 266.5%   
Sales per share (Unadj.) Rs1,028.5429.8 239.3%  
Earnings per share (Unadj.) Rs129.073.6 175.2%  
Cash flow per share (Unadj.) Rs186.087.4 212.9%  
Dividends per share (Unadj.) Rs68.0020.00 340.0%  
Dividend yield (eoy) %1.51.1 140.6%  
Book value per share (Unadj.) Rs753.6528.7 142.5%  
Shares outstanding (eoy) m23.0345.75 50.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.44.3 101.0%   
Avg P/E ratio x34.725.2 138.0%  
P/CF ratio (eoy) x24.121.2 113.6%  
Price / Book Value ratio x5.93.5 169.6%  
Dividend payout %52.727.2 194.1%   
Avg Mkt Cap Rs m103,17484,777 121.7%   
No. of employees `0003.62.8 127.6%   
Total wages/salary Rs m3,5923,039 118.2%   
Avg. sales/employee Rs Th6,537.76,925.9 94.4%   
Avg. wages/employee Rs Th991.41,070.4 92.6%   
Avg. net profit/employee Rs Th819.81,186.3 69.1%   
INCOME DATA
Net Sales Rs m23,68619,663 120.5%  
Other income Rs m7081,012 70.0%   
Total revenues Rs m24,39420,674 118.0%   
Gross profit Rs m5,2813,491 151.3%  
Depreciation Rs m1,313629 208.6%   
Interest Rs m1510 156.3%   
Profit before tax Rs m4,6613,864 120.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m01,304 0.0%   
Tax Rs m1,6911,801 93.9%   
Profit after tax Rs m2,9703,368 88.2%  
Gross profit margin %22.317.8 125.6%  
Effective tax rate %36.346.6 77.9%   
Net profit margin %12.517.1 73.2%  
BALANCE SHEET DATA
Current assets Rs m15,67320,789 75.4%   
Current liabilities Rs m6,6787,870 84.9%   
Net working cap to sales %38.065.7 57.8%  
Current ratio x2.32.6 88.8%  
Inventory Days Days7660 127.2%  
Debtors Days Days2222 99.5%  
Net fixed assets Rs m8,0989,175 88.3%   
Share capital Rs m230458 50.3%   
"Free" reserves Rs m17,08823,731 72.0%   
Net worth Rs m17,35624,189 71.8%   
Long term debt Rs m025 0.0%   
Total assets Rs m25,40032,706 77.7%  
Interest coverage x311.7403.5 77.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.6 155.1%   
Return on assets %11.810.3 113.8%  
Return on equity %17.113.9 122.9%  
Return on capital %26.921.4 126.0%  
Exports to sales %24.50-   
Imports to sales %28.00-   
Exports (fob) Rs m5,801NA-   
Imports (cif) Rs m6,627NA-   
Fx inflow Rs m7,14563 11,359.3%   
Fx outflow Rs m6,8464,067 168.3%   
Net fx Rs m299-4,004 -7.5%   
CASH FLOW
From Operations Rs m3,2263,288 98.1%  
From Investments Rs m-1,555-2,496 62.3%  
From Financial Activity Rs m-1,818-826 220.1%  
Net Cashflow Rs m-147-35 424.9%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 63.9 94.5%  
Indian inst/Mut Fund % 14.4 7.5 192.0%  
FIIs % 14.6 4.9 298.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 23.7 44.3%  
Shareholders   15,184 85,207 17.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare SANOFI INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens 99 Points Down; Vedanta & Coal India Top Losers(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.9% while the Hang Seng is down 2%. The Shanghai Composite is trading down by 2.7%.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jun 19, 2018 10:25 AM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - VENUS REMEDIES COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS